Abstract:Objective: Hormone therapy (HT) can relieve symptoms of menopause and treat chronic diseases. Its effectiveness in treating psychological symptoms is still debated. Several progestins can be used in HT, but their effects on mood, in particular depressive symptoms, is still unclear. This systematic review evaluates the evidence from randomized clinical trials with postmenopausal women on the effect of adjunctive progestins on symptoms of depression assessed by validated questionnaires. The primary aim was to evaluate scores on the Center for Epidemiologic Studies Depression Scale (CESD). The secondary aim was to assess scores on the Beck Depression Inventory (BDI), the Hamilton Depression Rating Scale (HAMD), and the Zung Self-Rating Depression Scale (SDS). Methods: A systematic review and meta-analysis were conducted to identify the most reliable evidence of the effects of progestin on depression to inform decision-making. A PICO- and PRISMA-based framework was established to formulate explicit and reasoned recommendations. The pre-/post-treatment effect was evaluated using standardized mean change (SMC). Results: We selected and analyzed 16 randomized clinical trials qualitatively and 12 studies quantitatively out of 9320 items identified. Most of the studies used medroxyprogesterone acetate as progestin. The results indicate that depressive symptoms do not increase with the addition of a progestin to estrogen HT. Depressive symptoms improved over time in the progestins-estrogen HT group, independent of progestin type (SMC CES-D -0.08 CI.95-0.10/-0.06, BDI -0.19 CI.95-0.32/-0.06, HAM-D -1.13 CI.95-1.47/-0.78, and SDS -0.11 CI.95-0.82/0.60). Yet similar effects were observed with estrogens alone and did not significantly differ from control groups on placebo. In one study, the addition of fluoxetine greatly increased the reduction of depressive symptoms observed with estrogen-progestin HT. Conclusions: In summary, in randomized clinical trials using validated questionnaires adjunctive progestin with estrogens did not increase depressive symptoms of postmenopausal women. Overall, depressive symptoms decreased with estrogen-progestin HT but also with estrogen alone. The decrease was not so pronounced to differ from controls on placebo. HT does not hamper the clinical efficacy of fluoxetine. The scarcity of randomized studies makes it difficult to determine the exact effect on depressive symptoms of different types of progestins. Project protocol registered in PROSPERO, registration number CRD42023454099.

The impact of menopause on antidepressant response: an explorative analysis from a real-world study

Effect of reproductive hormones and selective estrogen receptor modulators on mood during menopause

The intersection between menopause and depression: overview of research using animal models

The effectiveness of psychosocial interventions on non-physiological symptoms of menopause: A systematic review and meta-analysis

Female Depression before and after Menopause

Endocrine and psychosocial moderators of mindfulness-based stress reduction for the prevention of perimenopausal depressive symptoms: A randomized controlled trial

Pharmacological interventions and hormonal therapies for depressive symptoms in peri- and post-menopausal women: a network meta-analysis of randomized controlled trials

A review of the impact of hormone therapy on prefrontal structure and function at menopause

Targeted Analysis of Plasma Polar Metabolites in Postmenopausal Depression

Systematic review and meta-analysis of the effects of menopause hormone therapy on cognition

Neuroendocrine mechanisms of mood disorders during menopause transition: A narrative review and future perspectives

An influence of menopausal symptoms on mental health, emotion perception, and quality of life: a multi-faceted approach

The risk of depression in the menopausal stages: A systematic review and meta-analysis

Menopausal women struggling with symptoms at work – a conundrum unsolved?

Impact of natural menopause on multiple sclerosis: a multicentre study

Altered Spontaneous Brain Activity in Women During Menopause Transition and Its Association With Cognitive Function and Serum Estradiol Level

Systematic review and meta-analysis of the effects of progestins on depression in post-menopausal women: An evaluation of randomized clinical studies that used validated questionnaires

Effect of Women's Menopausal Complaints and Social Appearance Anxiety on Their Level of Depression, Stress, and Anxiety: A Cross-Sectional Study

Psychosocial factors promoting resilience during the menopausal transition

Exploring the Intersection of Depression, Anxiety, and Sexual Health in Perimenopausal Women

Menopause and its impact on the effectiveness of fremanezumab for migraine prophylaxis: post-hoc analysis of a prospective, real-world Greek registry